Avivagen Announces Agreement to Terminate China JV
August 07, 2018 08:00 ET
|
Avivagen Inc.
OTTAWA, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock,...
Avivagen Receives Approval from Health Canada for Use of OxC-beta™ in Companion Animal Supplements
June 27, 2018 06:30 ET
|
Avivagen Inc.
OTTAWA, Ontario, June 27, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for...
Avivagen Announces Largest Order To-Date for OxC-beta™ Livestock
June 25, 2018 06:30 ET
|
Avivagen Inc.
OTTAWA, June 25, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock,...
Avivagen to Exhibit Vivamune at SuperZoo
June 22, 2018 06:30 ET
|
Avivagen Inc.
OTTAWA, June 22, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV)(“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock,...
Avivagen Announces Distribution Agreement in Thailand
June 13, 2018 06:30 ET
|
Avivagen Inc.
OTTAWA, Ontario, June 13, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV)(“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for...
Avivagen Announces Q2 Financial Results
June 05, 2018 06:30 ET
|
Avivagen Inc.
OTTAWA, June 05, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSX-V:VIV) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock,...
Avivagen Announces Distribution in China for Vivamune
June 01, 2018 06:30 ET
|
Avivagen Inc.
OTTAWA, June 01, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV)(“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock,...
Avivagen Announces Approval of OxC-beta™ For Use in Livestock in New Zealand
May 30, 2018 06:30 ET
|
Avivagen Inc.
OTTAWA, May 30, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock,...
Avivagen to Pursue Regulatory Approval in Mexico
May 25, 2018 06:30 ET
|
Avivagen Inc.
OTTAWA, May 25, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV)(“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock,...
Avivagen Announces Drawdown from Credit Facility
May 22, 2018 06:30 ET
|
Avivagen Inc.
OTTAWA, May 22, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTCPink:CHEXF) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products...